Skip to main content

No evidence of Alzheimer’s pathology in younger carriers of Alzheimer’s gene

Submitted by Fiona McPherson on

Two studies indicate that young people carrying the “Alzheimer’s gene” (ApoE4) do not have the pathological changes found later in life. The first study, involving 1412 adolescents, found no differences in hippocampal volume or asymmetry as a function of gene status. The second study, involving 173 young adults (average age, 28 ± 7.6 years), found no difference in plasma concentrations of amyloid-beta peptides.

http://www.eurekalert.org/pub_releases/2014-04/ip-neo040614.php

Khan, W., Giampietro, V., Ginestet, C., Dell’Acqua, F., Bouls, D., Newhouse, S., … Simmons, A. (2014). No Differences in Hippocampal Volume between Carriers and Non-Carriers of the ApoE ε4 and ε2 Alleles in Young Healthy Adolescents. Journal of Alzheimer’s Disease, 40(1), 37-43. Retrieved from http://dx.doi.org/10.3233/JAD-131841 (Original work published 2014)

Zimmermann, R., Huber, E., Schamber, C., Lelental, N., Mroczko, B., Brandner, S., … Lewczuk, P. (2014). Plasma Concentrations of the Amyloid-β Peptides in Young Volunteers: The Influence of the APOE Genotype. Journal of Alzheimer’s Disease, 40(4), 1055-1060. Retrieved from http://dx.doi.org/10.3233/JAD-132687 (Original work published 2014)

Problems
Research
alzheimers genes
Alzheimer's Disease
risk factors
adolescence

Related News

How the Alzheimer’s gene increases risk

Submitted by Fiona McPherson on

We know that the E4 variant of the APOE gene greatly increases the risk of developing Alzheimer’s disease, but the reason is a little more mysterious. It has been thought that it makes it easier for amyloid plaques to form because it produces a protein that binds to amyloid beta. However, a new study shows that APOE and amyloid beta don’t bind together in cerebrospinal fluid and in fluids present outside cells grown in dishes, making it unlikely that they are binding together in the brain.

Gene doubles Alzheimer’s risk in African Americans

Submitted by Fiona McPherson on

A study involving nearly 6,000 African American older adults has found those with a specific gene variant have almost double the risk of developing late-onset Alzheimer’s disease compared with African Americans who lack the variant. The size of the effect is comparable to that of the ‘Alzheimer’s gene’, APOE-e4.

The gene (ABCA7) is involved in the production of cholesterol and lipids. It also affects the transport of several important proteins, including amyloid precursor protein, which is involved in the production of amyloid-beta.

Predicting memory loss in healthy older adults

In a study in which 78 healthy elders were given 5 different tests and then tested for cognitive performance 18 months later, two tests combined to correctly predict nearly 80% of those who developed significant cognitive decline. These tests were a blood test to identify presence of the ‘Alzheimer’s gene’ (APOE4), and a 5-minute fMRI imaging scan showing brain activity during mental tasks.

Diet rich in foods with Vitamin E may reduce Alzheimer’s disease risk

Two studies have come out in favor of a diet rich in foods containing vitamin E to help protect against Alzheimer's disease. One study involved 815 Chicago residents age 65 and older with no initial symptoms of mental decline, who were questioned about their eating habits and followed for an average of about four years. When factors like age and education were taken into account, those eating the most vitamin E-rich foods had a lower risk of developing Alzheimer’s, provided they did not have the ApoE e4 allele. This was not true when vitamin E was taken as a supplement.

Alzheimer's gene linked to red wine component

Submitted by Fiona McPherson on

A new discovery helps explain why the “Alzheimer’s gene” ApoE4 is such a risk factor. It appears that ApoE4 causes a dramatic reduction in SirT1, an "anti-aging protein" that is targeted by resveratrol (present in red wine). This reduction in SirT1 was associated with a change in the way the amyloid precursor protein (APP) was processed. Moreover, there was evidence that ‘bad’ tau and amyloid-beta could be prevented by increasing SirT1.

http://www.eurekalert.org/pub_releases/2013-10/bifa-mar101613.php

Alzheimer's gene worse for women

Submitted by Fiona McPherson on

Analysis of data from more than 8,000 people, most of them older than 60, has revealed that, among the 5,000 people initially tested cognitively normal, carrying one copy of the “Alzheimer’s gene” (ApoE4) only slightly increased men’s risk of developing MCI or Alzheimer’s — but nearly doubled women’s risk (healthy men with APOE4 were 27% more likely to develop MCI or Alzheimer’s compared to those without the gene, while female carriers had an 81% greater risk).

Genes involved in familial Alzheimer's disease

Submitted by Fiona McPherson on

Understanding a protein's role in familial Alzheimer's disease

Genetic engineering of human induced pluripotent stem cells has revealed very specifically how a key mutated protein is involved in familial Alzheimer's. Familial Alzheimer’s is a subset of early-onset Alzheimer's disease that is caused by inherited gene mutations.

Brain damage shown early when two parents with Alzheimer's

A small study involving 52 people aged 32-72 has found that those whose parents both had Alzheimer's disease showed more severe abnormalities in brain volume and metabolism and 5-10% more amyloid plaques in certain brain regions, compared to those with either a father or mother, or neither parent, with the disease. There were 13 in each group.

Consistent with previous research, those whose mother had Alzheimer's disease showed a greater level of the Alzheimer's disease biomarkers than those whose father had the disease.

Lower tau levels may obscure early Alzheimer’s in black patients

Data from 1,215 older adults, of whom 173 (14%) were African-American, has found that, although brain scans showed no significant differences between black and white participants, cerebrospinal fluid (CSF) showed significantly lower levels of the brain protein tau in African-Americans.

While both groups showed the same (expected) pattern of higher tau levels being associated with greater chance of cognitive impairment, the absolute amounts of tau protein were consistently lower in African-Americans.